U of M sets course for cure of fatal childhood skin disease

June 3, 2008,

Physicians at the University of Minnesota and University of Minnesota Children's Hospital, Fairview have set the path to a cure for a young boy's fatal genetic skin disease, recessive dystrophic epidermolysis bullosa (RDEB), by using a cord blood and bone marrow transplant. Nate Liao, a 25-month-old from Clarksburg, N.J., underwent the experimental therapy in October 2007.

"We have established a new standard of care for these EB patients, beginning with Nate," said John Wagner, M.D., the lead University of Minnesota Medical School physician who developed the clinical trial. "Nate's quality of life is forever changed."

Because they lack collagen type VII, children with RDEB have skin that is exquisitely delicate. The skin and lining of their gastrointestinal (GI) tract is fragile; tearing and blistering occur with minimal friction. Coughing and vomiting often result in tears in the lining of the esophagus and stomach. Those affected must have their entire body continuously wrapped in bandages. Those who do not succumb from malnutrition and infection in childhood will acquire a uniformly fatal, aggressive cancer of the skin in young adulthood.

In collaboration with Angela M. Christiano, Ph.D., professor of dermatology and genetics and development at Columbia University Medical Center (New York, N.Y.), and investigators at Asahikawa Medical College (Asahikawa, Japan), and Jefferson Medical College (Philadelphia, Penn.), University of Minnesota researchers, Jakub Tolar, M.D., Ph.D., and Bruce Blazar, M.D., discovered that certain stem cells found in bone marrow could correct the biochemical defect in RDEB in a mouse model of the disease. Marrow-derived stem cells greatly lengthened the life expectancy of the mice and healed existing blisters. Further testing by Columbia demonstrated that for the first time, these mice were producing collagen type VII and anchoring fibrils, the structures needed to bind skin to the body.

This is the first time physicians have approached the treatment of RDEB from a systemic perspective, using marrow-derived stem cells as a means to replace the missing protein, collagen type VII, throughout the body. Through the infusion of cells obtained from a healthy donor, the stem cells produce collagen type VII and correct the underlying genetic defect.

In October 2007, Nate Liao received marrow- and umbilical cord blood-derived stem cells and progenitor cells from his healthy, tissue-matched brother. Over the next six months, the skin and lining of his GI tract slowly improved, and skin biopsies on days 60, 130, and 200 documented increasing amounts of collagen type VII. By day 130, Nate's skin and the lining of his GI tract were beginning to show clinical signs that his skin was anchoring to his body.

Wagner and his team sought an external review of the skin biopsies. Photographs of the biopsies have been sent to dermatopathologists in London, England, and Portland, Ore., for independent analysis. Based on the success seen in Nate, Wagner will enroll additional RDEB patients into the clinical trial. Jacob Liao, Nate's brother who also has RDEB, received an unrelated donor cord blood transplant on May 30.

Source: University of Minnesota

Explore further: Researchers identify a novel periodic autoinflammatory syndrome

Related Stories

Researchers identify a novel periodic autoinflammatory syndrome

January 30, 2018
A research team from the University of Helsinki, Helsinki University Hospital and Folkhälsan Institute of Genetics in Helsinki, Finland, has identified a new genetic mutation that alters the function of cryopyrin and leads ...

Warm-air blowers direct pathogens to surgical site, computer model shows

January 26, 2018
Warm-air blowers that keep patients at a safe temperature also interfere with operating room ventilation systems, potentially making it easier for microbial skin colonizers to cause infection at surgical sites.

Unexpected helpers in wound healing

January 24, 2018
Nerve cells in the skin help wounds to heal. When an injury occurs, cells known as glial cells change into repair cells and disseminate into the wound, where they help the skin to regenerate, researchers from the University ...

Tumor imaging technique has potential as anti-cancer weapon, mouse study shows

January 26, 2018
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy—which is limited to the skin and areas accessible with an endoscope—this technique can target and attack cancer cells that ...

Guidelines of care developed for skin cancer management

January 22, 2018
(HealthDay)—Guidelines of care have been developed for the management of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), according to two reports published online Jan. 10 in the Journal of the American ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Recommended for you

For children with respiratory infections, antibiotics with narrower targets are better

January 30, 2018
When doctors prescribe antibiotics for children with common respiratory infections, a more selective approach is better. Researchers who studied pediatric treatment practices in 30,000 patients with earaches, strep throat ...

Study of polio in Pakistan shows insecurity a barrier to eradication

January 30, 2018
A team of researchers from Canada, the U.S. and the U.K. has found that insecurity in a country or region can be a barrier to eradication of a disease such as polio. In their paper published in Proceedings of the National ...

Diabetes makes bones less bendable, more prone to fracture

January 29, 2018
Besides impairing cardiovascular and kidney function, Type 2 diabetes is known to be a risk factor for bone fractures – but exactly how diabetes makes bones more fragile has been unclear.

Bacteria block transmission of Zika and Dengue viruses

January 26, 2018
Scientists at the University of Glasgow's MRC Centre for Virus Researchopens (CVR) have found a bacterial strain which blocks dengue and Zika virus transmission from mosquitoes.

Study: Site of first chlamydia exposure makes big difference

January 26, 2018
Exposing the gut to chlamydia protects against subsequent infection in the genital tract and other tissues, researchers from UT Health San Antonio discovered. Chlamydia is the nation's most common sexually transmitted disease ...

Repurposed drug found to be effective against Zika virus

January 25, 2018
In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus—and blocked transmission of the virus to mouse fetuses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.